Global Tuberculosis Vaccine Treatment Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Tuberculosis Vaccine Treatment Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.



Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.

According to our (Global Info Research) latest study, the global Tuberculosis Vaccine Treatment market size was valued at US$ 78.5 million in 2023 and is forecast to a readjusted size of USD 95.3 million by 2030 with a CAGR of 2.8% during review period.

In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.

The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.

Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.

Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.

This report is a detailed and comprehensive analysis for global Tuberculosis Vaccine Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Tuberculosis Vaccine Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/K Dose), 2019-2030

Global Tuberculosis Vaccine Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/K Dose), 2019-2030

Global Tuberculosis Vaccine Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/K Dose), 2019-2030

Global Tuberculosis Vaccine Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (USD/K Dose), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Tuberculosis Vaccine Treatment

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Tuberculosis Vaccine Treatment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Tuberculosis Vaccine Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Immune Vaccine
Therapy Vaccine

Market segment by Application
Self-Procurement
UNICEF
Other

Major players covered
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Tuberculosis Vaccine Treatment product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Tuberculosis Vaccine Treatment, with price, sales quantity, revenue, and global market share of Tuberculosis Vaccine Treatment from 2019 to 2024.

Chapter 3, the Tuberculosis Vaccine Treatment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Tuberculosis Vaccine Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Tuberculosis Vaccine Treatment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Tuberculosis Vaccine Treatment.

Chapter 14 and 15, to describe Tuberculosis Vaccine Treatment sales channel, distributors, customers, research findings and conclusion.